Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Rab10em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Rab10em1/Cya

Common Name
Rab10-KO
Product ID
S-KO-18769
Backgroud
C57BL/6JCya
Strain ID
KOCMP-19325-Rab10-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Rab10-KO Mouse (Catalog S-KO-18769) were purchased from Cyagen.”
KO Models
AMPK signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
AMPK signaling pathway
Basic Information
Strain Name
Rab10-KO
Strain ID
KOCMP-19325-Rab10-B6J-VA
Gene Name
Rab10
Product ID
S-KO-18769
Gene Alias
--
Background
C57BL/6JCya
NCBI ID
19325 (Mouse)
Modification
Conventional knockout
Chromosome
Chr 12 (Mouse)
Phenotype
MGI:105066
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000021001
NCBI Transcript ID
NM_016676
Target Region
Exon 3
Size of Effective Region
~1.0 kb
Overview of Gene Research
Rab10, a member of the small GTPase family, is involved in multiple cellular trafficking processes. It plays a role in the formation of recycling endosomal compartments like tubular endosomes through interaction with kinesin motors KIF13A and KIF13B [10]. Rab10 is also associated with pathways related to cell migration, lysosomal function, and is implicated in several disease conditions, making it a potential biomarker or drug target.

In Alzheimer's disease, a rare variant in the 3'-UTR of RAB10 has been identified as protective, indicating its possible role in disease resilience [2]. In Parkinson's disease, genetic variation at the LRRK2 locus, which can phosphorylate Rab10, is linked to disease risk. Lysosomal positioning regulates Rab10 phosphorylation by LRRK2, and loss of VPS13C, associated with early-onset Parkinson's disease, disrupts phospho-Rab10-mediated lysosomal function [4,5]. Also, urinary Rab10 phosphorylation is elevated in idiopathic Parkinson disease and is associated with disease progression [7]. In hepatocellular carcinoma, O-GlcNAcylation of RAB10 by OGT stabilizes it, accelerating cancer progression [3]. In breast cancer, RAB10 expression is elevated, promoting cell proliferation, migration, and invasion, and predicting a poor prognosis [9]. Moreover, Rab10-CAV1 mediated intraluminal vesicle transport to migrasomes is important for intercellular communication during skin wound healing [1]. Heterozygous Rab10 knock-out mice show changes in pathways related to neuronal metabolism, inflammation, and aging, and perform differently in hippocampal-dependent tasks, suggesting Rab10's role in controlling brain circuitry [6]. Rab10 also regulates lysosome exocytosis and plasma membrane repair [8].

In conclusion, Rab10 is crucial for multiple cellular functions such as endosomal formation, vesicle transport, and lysosomal function. Studies using gene knockout mouse models have revealed its significant roles in neurodegenerative diseases like Alzheimer's and Parkinson's, as well as in cancer. Understanding Rab10's functions provides insights into disease mechanisms and potential therapeutic targets.

References:
1. Li, Yong, Wen, Yiling, Li, Ying, Wong, Catherine C L, Chen, Yang. 2024. Rab10-CAV1 mediated intraluminal vesicle transport to migrasomes. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2319267121. doi:10.1073/pnas.2319267121. https://pubmed.ncbi.nlm.nih.gov/39008679/
2. Tavana, Justina P, Rosene, Matthew, Jensen, Nick O, Kauwe, John Sk, Karch, Celeste M. 2018. RAB10: an Alzheimer's disease resilience locus and potential drug target. In Clinical interventions in aging, 14, 73-79. doi:10.2147/CIA.S159148. https://pubmed.ncbi.nlm.nih.gov/30643396/
3. Lv, Zhuo, Ma, Guolu, Zhong, Zhuo, Li, Bin, Long, De. . O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression. In Carcinogenesis, 44, 785-794. doi:10.1093/carcin/bgad034. https://pubmed.ncbi.nlm.nih.gov/37218374/
4. Kluss, Jillian H, Beilina, Alexandra, Williamson, Chad D, Cookson, Mark R, Bonet-Ponce, Luis. 2022. Lysosomal positioning regulates Rab10 phosphorylation at LRRK2+ lysosomes. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2205492119. doi:10.1073/pnas.2205492119. https://pubmed.ncbi.nlm.nih.gov/36256825/
5. Schrӧder, Leonie F, Peng, Wesley, Gao, Ge, Schwake, Michael, Krainc, Dimitri. 2024. VPS13C regulates phospho-Rab10-mediated lysosomal function in human dopaminergic neurons. In The Journal of cell biology, 223, . doi:10.1083/jcb.202304042. https://pubmed.ncbi.nlm.nih.gov/38358348/
6. Bunner, Wyatt, Wang, Jie, Cohen, Sarah, Yasuda, Ryohei, Szatmari, Erzsebet M. 2023. Behavioral and Transcriptome Profiling of Heterozygous Rab10 Knock-Out Mice. In eNeuro, 10, . doi:10.1523/ENEURO.0459-22.2023. https://pubmed.ncbi.nlm.nih.gov/37156612/
7. Wang, Shijie, Unnithan, Shakthi, Bryant, Nicole, Al-Khalidi, Hussein R, West, Andrew B. 2022. Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease. In Movement disorders : official journal of the Movement Disorder Society, 37, 1454-1464. doi:10.1002/mds.29043. https://pubmed.ncbi.nlm.nih.gov/35521944/
8. Vieira, Otilia V. 2016. Rab3a and Rab10 are regulators of lysosome exocytosis and plasma membrane repair. In Small GTPases, 9, 349-351. doi:10.1080/21541248.2016.1235004. https://pubmed.ncbi.nlm.nih.gov/27687479/
9. Zhuo, Jian, Han, Jianjun, Zhao, Yanchun, Yang, Xiaohong, Liu, Weiguang. 2023. RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer. In Scientific reports, 13, 15252. doi:10.1038/s41598-023-42434-1. https://pubmed.ncbi.nlm.nih.gov/37709911/
10. Etoh, Kan, Fukuda, Mitsunori. 2019. Rab10 regulates tubular endosome formation through KIF13A and KIF13B motors. In Journal of cell science, 132, . doi:10.1242/jcs.226977. https://pubmed.ncbi.nlm.nih.gov/30700496/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research